Beijing Cancer Hospital — Beijing, Beijing Municipality

Public research footprint of Beijing Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

1,176

Registered studies

523

Active

302

Recruiting now

308

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer (NSCLC) · Solid Tumors · B-cell Non-Hodgkin Lymphoma (B-NHL) · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT05382559 — A Study of ASP3082 in Adults With Advanced Solid Tumors (Recruiting)
NCT06470438 — A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Beijing Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.